RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,361,074 | -42.0% | 3,112,106 | -30.8% | 0.00% | -33.3% |
| Q2 2023 | $5,799,527 | +83793.1% | 4,495,757 | -14.2% | 0.00% | -25.0% |
| Q1 2023 | $6,913 | +44.6% | 5,237,117 | +64.3% | 0.00% | +33.3% |
| Q4 2022 | $4,782 | -99.9% | 3,188,278 | -55.7% | 0.00% | -40.0% |
| Q3 2022 | $8,499,000 | +1100.4% | 7,202,938 | +1049.5% | 0.01% | – |
| Q2 2022 | $708,000 | -90.5% | 626,642 | -74.9% | 0.00% | -100.0% |
| Q1 2022 | $7,473,000 | -38.0% | 2,499,480 | -45.0% | 0.00% | -33.3% |
| Q4 2021 | $12,049,000 | -18.0% | 4,546,869 | +12.3% | 0.01% | -33.3% |
| Q3 2021 | $14,701,000 | -26.8% | 4,049,924 | -12.5% | 0.01% | -25.0% |
| Q2 2021 | $20,092,000 | +59.7% | 4,629,583 | +25.8% | 0.01% | +33.3% |
| Q1 2021 | $12,581,000 | +249.5% | 3,678,755 | +257.7% | 0.01% | +200.0% |
| Q4 2020 | $3,600,000 | +136.7% | 1,028,480 | +62.3% | 0.00% | +50.0% |
| Q3 2020 | $1,521,000 | +47.2% | 633,842 | +12.3% | 0.00% | +100.0% |
| Q2 2020 | $1,033,000 | -91.9% | 564,289 | -93.1% | 0.00% | -96.6% |
| Q1 2020 | $12,736,000 | -30.2% | 8,163,989 | -4.2% | 0.03% | +26.1% |
| Q4 2019 | $18,244,000 | +27.6% | 8,525,418 | +11.5% | 0.02% | 0.0% |
| Q3 2019 | $14,301,000 | -18.9% | 7,648,121 | +13.3% | 0.02% | -11.5% |
| Q2 2019 | $17,624,000 | -1.8% | 6,752,437 | -3.3% | 0.03% | -3.7% |
| Q1 2019 | $17,952,000 | +13.5% | 6,985,308 | +1.6% | 0.03% | +8.0% |
| Q4 2018 | $15,814,000 | -35.4% | 6,875,804 | -9.9% | 0.02% | -16.7% |
| Q3 2018 | $24,498,000 | +162.3% | 7,631,800 | +131.3% | 0.03% | +150.0% |
| Q2 2018 | $9,339,000 | -47.3% | 3,300,077 | -34.1% | 0.01% | -50.0% |
| Q1 2018 | $17,731,000 | -18.0% | 5,008,672 | -10.1% | 0.02% | -20.0% |
| Q4 2017 | $21,628,000 | +213.0% | 5,574,333 | +104.9% | 0.03% | +172.7% |
| Q3 2017 | $6,909,000 | -48.6% | 2,719,919 | -44.7% | 0.01% | -54.2% |
| Q2 2017 | $13,432,000 | +33.5% | 4,920,182 | +61.9% | 0.02% | +33.3% |
| Q1 2017 | $10,058,000 | +170.5% | 3,038,693 | +94.5% | 0.02% | +125.0% |
| Q4 2016 | $3,718,000 | -55.0% | 1,562,075 | -30.7% | 0.01% | -42.9% |
| Q3 2016 | $8,268,000 | +56.8% | 2,252,688 | -4.7% | 0.01% | +16.7% |
| Q2 2016 | $5,272,000 | +8.1% | 2,364,117 | +0.8% | 0.01% | 0.0% |
| Q1 2016 | $4,879,000 | -21.3% | 2,345,756 | +14.7% | 0.01% | -7.7% |
| Q4 2015 | $6,198,000 | +49.6% | 2,045,596 | +21.9% | 0.01% | +62.5% |
| Q3 2015 | $4,143,000 | -26.5% | 1,677,440 | -4.5% | 0.01% | -27.3% |
| Q2 2015 | $5,639,000 | -13.2% | 1,756,645 | -3.4% | 0.01% | -8.3% |
| Q1 2015 | $6,493,000 | +45.2% | 1,818,792 | -7.7% | 0.01% | +33.3% |
| Q4 2014 | $4,471,000 | -24.6% | 1,969,559 | -35.6% | 0.01% | -40.0% |
| Q3 2014 | $5,930,000 | -8.3% | 3,056,497 | +71.6% | 0.02% | -16.7% |
| Q2 2014 | $6,465,000 | -26.4% | 1,780,917 | -21.4% | 0.02% | -28.0% |
| Q1 2014 | $8,789,000 | -6.1% | 2,265,276 | -31.0% | 0.02% | -16.7% |
| Q4 2013 | $9,358,000 | -9.6% | 3,283,551 | +13.6% | 0.03% | -9.1% |
| Q3 2013 | $10,349,000 | +71.8% | 2,890,716 | +60.3% | 0.03% | +83.3% |
| Q2 2013 | $6,024,000 | – | 1,803,567 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |